What are the likely causes and recommended work‑up for a patient with hepatomegaly on ultrasound, elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and normal alkaline phosphatase, alpha‑fetoprotein (AFP), carcinoembryonic antigen (CEA), cancer antigen 19‑9 (CA 19‑9), anti‑hepatitis C virus (anti‑HCV) antibodies, and hepatitis B surface antigen (HBsAg)?

Hepatocellular Pattern Liver Injury: Most Likely NAFLD or Alcohol-Related

This patient has a hepatocellular pattern of liver injury (elevated AST/ALT with normal ALP), and with viral hepatitis and malignancy excluded, the most likely diagnoses are nonalcoholic fatty liver disease (NAFLD) or alcohol-induced liver disease—the two most common causes of this presentation 1.

Diagnostic Approach

Calculate the AST:ALT Ratio

• AST:ALT ratio <1: Strongly suggests NAFLD/metabolic liver disease 1
• AST:ALT ratio >2: Highly suggestive of alcohol-induced liver disease 2
• AST:ALT ratio >3: Very specific for alcoholic liver disease 2

Immediate History Requirements

Alcohol intake assessment:

• Current and past consumption in units per week
• Use AUDIT-C questionnaire (score ≥8 is positive) 3
• Number of heavy drinking days in the past year 2

Metabolic syndrome features:

• Central obesity/waist circumference
• Hypertension
• Diabetes or insulin resistance
• Dyslipidemia 3, 4

Medication review:

• All prescribed medications
• Over-the-counter drugs
• Herbal supplements
• Recent medication changes 5, 3

Required Laboratory Work-Up

Core Panel (Order Now):

• Fasting lipid profile
• Fasting glucose or HbA1c
• Complete blood count with platelets
• Serum albumin and prothrombin time (assess synthetic function) 5, 3
• Serum iron, ferritin, and total iron-binding capacity (hemochromatosis screening—transferrin saturation >45% warrants referral) 3, 4

Extended Panel (If Core Panel Unremarkable):

• Anti-smooth muscle antibody, ANA, anti-LKM1 (autoimmune hepatitis)
• Serum protein electrophoresis with immunoglobulins (elevated IgG suggests autoimmune hepatitis)
• Ceruloplasmin (Wilson disease—consider especially if age <40)
• Alpha-1 antitrypsin level and phenotype 1, 4
• Thyroid function tests (extrahepatic cause) 4, 6

Imaging Strategy

Abdominal ultrasound is the appropriate next imaging step 1. The ultrasound already performed showing hepatomegaly should be reviewed for:

• Steatosis (echogenic liver texture—84.8% sensitivity and 93.6% specificity for moderate-severe fatty infiltration >30%) 1
• Cirrhotic changes (nodular contour, coarse echotexture)
• Focal lesions
• Bile duct dilation (should be absent given normal ALP)

Important Caveat:

Ultrasound cannot reliably distinguish between glycogenosis (in poorly controlled diabetes) and steatosis 7. Both appear as hepatomegaly with increased echogenicity, but glycogenosis is completely reversible with glycemic control and does not progress to cirrhosis, whereas steatosis can progress to fibrosis 7.

Uncommon But Important Causes to Exclude

Drug-Induced Liver Injury

Review all medications including recent additions. This is an uncommon but critical reversible cause 1, 4.

Hereditary Hemochromatosis

Check ferritin and transferrin saturation. However, isolated elevated ferritin is commonly seen in NAFLD and alcohol excess (dysmetabolic iron overload syndrome) and does NOT indicate hemochromatosis 3. Only refer if transferrin saturation >45% with elevated ferritin.

Autoimmune Hepatitis

Can present identically to this case. Check autoantibodies and IgG levels 1, 8.

Wilson Disease

Rare but treatable. Consider if age <40 years (though cases up to 8th decade reported). Check ceruloplasmin and consider slit-lamp examination for Kayser-Fleischer rings 8.

Hepatic Glycogenosis

If patient has poorly controlled diabetes, hepatomegaly with elevated transaminases may be due to glycogen accumulation rather than steatosis. This is completely reversible with sustained euglycemic control and does not progress to cirrhosis 7. Normal ALP and synthetic function support this diagnosis.

Management Algorithm

If metabolic syndrome features present and testing unremarkable:

1. Trial of lifestyle modification (weight loss, exercise, dietary changes)
2. Optimize glycemic control if diabetic
3. Recheck liver enzymes in 3-6 months 3, 4

If elevation persists >6 months or worsens:

• Consider hepatology referral
• May need liver biopsy to distinguish simple steatosis from NASH and assess fibrosis 1
• Consider noninvasive fibrosis assessment (FibroScan/transient elastography or FibroTest) 9

Immediate referral indicated if:

• Evidence of hepatic decompensation (ascites, encephalopathy, coagulopathy)
• Abnormal albumin or prolonged prothrombin time
• Positive autoimmune markers with elevated IgG
• Transferrin saturation >45% with elevated ferritin
• Age <40 with unexplained hepatomegaly (consider Wilson disease) 8, 3

Key Pitfalls to Avoid

1. Do not assume isolated elevated ferritin = hemochromatosis—it's commonly elevated in NAFLD and alcohol excess 3
2. Do not repeat the same tests without investigating the cause—84% of abnormal liver tests remain abnormal at 1 month 3
3. Do not overlook diabetes-related glycogenosis—this mimics steatosis on ultrasound but is completely reversible 7
4. Do not ignore the AST:ALT ratio—it provides critical diagnostic information about alcohol vs. metabolic etiology 1, 2